US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Y mAbs Therapeutics Inc (YMAB)
Y mAbs Therapeutics Inc (YMAB) ニュース

YMAB

Y mAbs Therapeutics (YMAB)

Y mAbs Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:YMAB

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/01/23	09 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2025/01/23	09 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2025/01/23	09 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2025/01/23	09 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2025/01/23	08 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2025/01/18	06 : 18	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2025/01/17	06 : 44	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2025/01/13	23 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2025/01/10	23 : 27	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2025/01/10	23 : 26	GlobeNewswire Inc.	Correcting & Replacing – Y-mAbs Provides Strategic Business Update and 2025 Priorities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2025/01/10	21 : 35	GlobeNewswire Inc.	Y-mAbs Appoints Experienced Commercial Leader as Head of DANYELZA Business Unit	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2025/01/10	21 : 05	GlobeNewswire Inc.	Y-mAbs Provides Strategic Business Update and 2025 Priorities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/12/23	21 : 30	GlobeNewswire Inc.	Y-mAbs to Present at the 43rd Annual J.P. Morgan Healthcare Conference	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/12/08	02 : 00	GlobeNewswire Inc.	Y-mAbs Presents SADA Platform Preclinical Data and Trial in Progress Posters at the 2024 American Society Hematology (ASH) Annual Meeting	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/11/27	21 : 35	GlobeNewswire Inc.	Y-mAbs to Participate at Citi’s 2024 Global Healthcare Conference	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/11/15	06 : 32	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/11/08	21 : 18	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/11/08	20 : 55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/11/08	20 : 35	GlobeNewswire Inc.	Y-mAbs Reports Third Quarter 2024 Financial Results and Recent Corporate Developments	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/11/04	22 : 51	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/11/04	21 : 35	GlobeNewswire Inc.	Y-mAbs and Nobelpharma Announce Exclusive License and Distribution Agreement for DANYELZA® (naxitamab-gqgk) in Japan	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/10/25	20 : 05	GlobeNewswire Inc.	Y-mAbs Announces Third Quarter 2024 Conference Call and Webcast	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/10/01	20 : 05	GlobeNewswire Inc.	Y-mAbs to Participate in Upcoming Investor Conferences in October	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/09/21	05 : 16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/09/21	05 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/09/18	09 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/09/18	06 : 24	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/09/14	05 : 19	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/09/06	20 : 30	GlobeNewswire Inc.	Y-mAbs Presents Neuroblastoma Research on Naxitamab and SADA PRIT Technology Platform at AACR Special Conference on Advances in Pediatric Cancer Research	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/09/04	06 : 00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:YMAB	Y mAbs Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:YMAB

1 2 3 4 5 6 7 8 9 10 次へ >>

US Dollar vs Sterling

BNP Paribas (QX)

Financial Select Sector

Deutsche Telekom (QX)

Health Care Select Sector

Invesco QQQ Trust Series 1

Bank of America

Gold vs US Dollar

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約